ژورنال کلاپ | مرکز تحقیقات غدد و متابولیسم

ردیف	عنوان	تاریخ ارائه	توضیحات
1	JC265	1401/12/05	Risk Factors for the Development of Retinopathy in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Experience
2	JC266	1401/09/07	Empagliflozin in Heart Failure with a Preserved Ejection Fraction
3	JC265	1400/04/03	Clinical Outcomes After Discontinuation of Thyroid Hormone Replacement - A Systematic Review and Meta-Analysis
4	JC264	1400/04/03	Association of metabolic–bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174 772 participants
5	jc263	1400/03/27	Statins Decrease the Risk of Orbitopathy in Newly Diagnosed Patients with Graves Disease
6	JC262	1400/03/27	Late Recovery of Parathyroid Function after Total Thyroidectomy in Children and Adults: Is There a Difference?
7	JC261	1400/03/20	A Randomized Trial of Empagliﬂozin to Increase Plasma Sodium Levels in Patients with the Syndrome of Inappropriate Antidiuresis
8	JC260	1400/03/20	Osteoporosis, Fractures, and Bone Mineral Density Screening in Veterans With Kidney Stone Disease
9	JC259	1400/03/13	Which parameters predict the beneficial effect of GnRHa treatment on height in girls with central precocious puberty?
10	JC258	1400/03/06	Long-term efficacy and safety of percutaneous ethanol injection (PEI) in cystic thyroid nodules: A systematic review and meta-analysis
11	JC257	1400/03/06	Urinary polycyclic aromatic hydrocarbons and sex hormones in children and adolescents: Evidence from NHANES
12	JC255	1400/02/30	Prevalence of Iodine-Induced Hyperthyroidism After Administration of Iodinated Contrast During Radiographic Procedures: A Systematic Review and Meta-Analysis of the Literature
13	JC256	1400/02/30	Indications and Strategy for Active Surveillance of Adult Low-Risk Papillary Thyroid Microcarcinoma: Consensus Statements from the Japan Association of Endocrine Surgery Task Force on Management for Papillary Thyroid Microcarcinoma
14	JC254	1400/02/16	High Diagnostic Accuracy of Subcutaneous Triptorelin test Compared with GnRH test for Diagnosing Central Precocious Puberty in Girls
15	JC253	1400/02/16	Therapeutic Equivalence of a New Preparation of Liquid Levothyroxine with Tablets in Patients with Overt Primary Hypothyroidism
16	JC251	1400/02/09	Rapid Changes in Serum Testosterone in Men With Newly Diagnosed Type 2 Diabetes With Intensive Insulin and Metformin
17	JC252	1400/02/09	Insulin resistance and bone health in adolescents
18	JC250	1400/02/02	Subclinical Hypothyroidism
19	JC249	1400/02/02	Renal and Cardiovascular Effects of SGLT2 Inhibition in Combination with Loop Diuretics in Patients with Type 2 Diabetes and Chronic Heart Failure: The RECEDE-CHF Trial
20	JC247	1400/01/26	Endocrine Disruptors and Polycystic Ovary Syndrome: Phthalates
21	JC248	1400/01/26	Association of Thyroid Hormone Therapy with Mortality in Subclinical Hypothyroidism: A Systematic Review and Meta-analysis
22	JC246	1400/01/19	Cystic Adrenal Lesions: Focus on Pediatric Population (A Review)
23	JC245	1400/01/19	Once-Weekly Semaglutide in Adults with Overweight or Obesity
24	JC243	1398/02/07	Risk of Meningioma in European Patients Treated With Growth Hormone in Childhood: Results From the SAGhE Cohort
25	JC244	1398/02/07	Primary Hyperparathyroidism in Pregnancy: Maternofetal Outcomes at a Quaternary Referral Obstetric Hospital, 2000 Through 2015
26	JC242	1398/01/31	Lipid-Lowering Agents in Older Individuals: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
27	JC241	1398/01/31	Body-Weight Fluctuation and Incident Diabetes Mellitus, Cardiovascular Disease, and Mortality: A 16-Year Prospective Cohort Study
28	JC239	1398/01/24	Accuracy of Anti-Müllerian Hormone and total Follicles Count to Diagnose Polycystic Ovary Syndrome in Reproductive Women
29	JC240	1398/01/24	Systemic Thyroid Hormone Status During Levothyroxine Therapy in Hypothyroidism: A Systematic Review and Meta-Analysis
30	JC238	1398/01/17	The Natural History of Adrenal Insufficiency in X-Linked Adrenoleukodystrophy: An International Collaboration
31	JC237	1398/01/17	Levothyroxine in Women with Thyroid Peroxidase Antibodies before Conception
32	JC235	1397/12/18	The Efficacy of 24-Month Metformin for Improving Menses, Hormones, and Metabolic Profiles in Polycystic Ovary Syndrome
33	JC236	1397/12/18	Clinical Practice Update on Testosterone Therapy for Male Hypogonadism: Contrasting Perspectives to Optimize Care
34	JC234	1397/12/11	One-Hour and Twe-Hour Postload Glucose Level on Oral Glucose Tolerance Test and the Risk of Incident Metabolic Syndrome
35	JC233	1397/12/11	Effects of Glucagon-Like Peptide-1 Receptor Agonists on Hypothalamic-Pituitary-Adrenal Axis in Healthy Volunteers
36	JC231	1397/12/04	DEXAMETHASONE STRESS TEST: A PILOT CLINICAL STUDY FOR IDENTIFICATION OF INDIVIDUALS HIGHLY PRONE TO DEVELOP TYPE 2 DIABETES
37	JC232	1397/12/04	Gestational Weight Gain in Women With Polycystic Ovary Syndrome: A Controlled Study
38	JC230	1397/11/27	Efficacy and safety of once-weekly dulaglutide versus insulin glargine in mainly Asian patients with type 2 diabetes mellitus on metformin and - or a sulphonylurea: A 52-week open-label, randomized phase III trial
39	JC229	1397/11/27	Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
40	JC227	1397/11/13	Effects of SGLT2 Inhibitors on Circulating Stem and Progenitor Cells in Patients With Type 2 Diabetes
41	JC228	1397/11/13	Marine n−3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer
42	JC226	1397/11/06	Reducing the Number of Unnecessary Thyroid Biopsies While Improving Diagnostic Accuracy
43	JC225	1397/11/06	Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease
44	JC223	1397/10/29	Effects of Altering Levothyroxine Dose on Energy Expenditure and Body Composition in Subjects Treated With LT4
45	JC224	1397/10/29	Radioactive Iodine–Related Clonal Hematopoiesis in Thyroid Cancer Is Common and Associated With Decreased Survival
46	JC222	1397/10/22	High-Dose, Diazoxide-Mediated Insulin Suppression Boosts Weight Loss Induced by Lifestyle Intervention
47	JC221	1397/10/22	Association Between Primary Hypothyroidism and Nonalcoholic Fatty Liver Disease
48	JC219	1397/10/15	Microvascular Outcomes in Patients With Diabetes After Bariatric Surgery Versus Usual Care
49	JC220	1397/10/15	Smoking Cessation, Weight Change, Type 2 Diabetes, and Mortality
50	JC218	1397/10/08	Cardiovascular and Metabolic Outcomes in Congenital Adrenal Hyperplasia
51	JC217	1397/10/01	Effects of n−3 Fatty Acid Supplements in Diabetes Mellitus
52	JC215	1397/09/24	Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
53	JC214	1397/09/24	Lactating Mothers and Infants Residing in an Area with an Effective Salt Iodization Program Have No Need for Iodine Supplements: Results from a Double-Blind, Placebo-Controlled, Randomized Controlled Trial
54	JC216	1397/09/24	PCSK9 — A Journey to Cardiovascular Outcomes
55	JC213	1397/09/17	The Association of Maternal Thyroid Autoimmunity During Pregnancy With Child IQ
56	JC212	1397/09/17	Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes
57	JC211	1397/09/10	Iron Deficiency May Predict Greater Risk for Hypothyroxinemia: A Retrospective Cohort Study of Pregnant Women in China
58	JC210	1397/09/10	Fracture Prevention with Zoledronate in Older Women with Osteopenia
59	JC209	1397/09/03	A Comparison of the 2017 American College of Cardiology / American Heart Association Blood Pressure Guideline and the 2017 American Diabetes Association Diabetes and Hypertension Position Statement for U.S. Adults With Diabetes
60	JC208	1397/09/03	Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus
61	JC207	1397/08/26	Gut Microbiota Differs in Composition and Functionality Between Children With Type 1 Diabetes and MODY2 and Healthy Control Subjects: A Case-Control Study
62	JC206	1397/08/26	Effects of Long-Term Denosumab on Bone Histomorphometry and Mineralization in Women With Postmenopausal Osteoporosis
63	JC205	1397/08/19	Somatostatin Analogs and Glucose Metabolism in Acromegaly: A Meta-Analysis of Prospective Interventional Studies
64	JC204	1397/08/19	Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial
65	JC203	1397/08/12	Benign Thyroid Diseases and Risk of Thyroid Cancer: A Nationwide Cohort Study
66	JC202	1397/08/12	Limitations of the 2015 ATA Guidelines for Prediction of Thyroid Cancer: A Review of 1947 Consecutive Aspirations
67	JC201	1397/08/05	Statin Use Is Associated With Decreased Osteoporosis and Fracture Risks in Stroke Patients
68	JC200	1397/08/05	Association of Vitamin D Deficiency With Peripheral Arterial Disease
69	JC199	1397/07/28	One-Hour Postload Hyperglycemia: Implications for Prediction and Prevention of Type 2 Diabetes
70	JC198	1397/07/28	Association Between Diabetic Retinopathy and Parkinson Disease: The Korean National Health Insurance Service Database
71	JC197	1397/07/21	Prospective Validation of ATA and ETA Sonographic Pattern Risk of Thyroid Nodules Selected for FNAC
72	JC196	1397/07/21	Persistence of Diabetes and Hypertension After Multimodal Treatment of Acromegaly
73	JC195	1397/07/14	2018European Thyroid Association (ETA) Guidelines for the Management of Amiodarone-Associated Thyroid Dysfunction
74	JC194	1397/07/14	Effectiveness of Prenatal Vitamin D Deficiency Screening and Treatment Program: A Stratified Randomized Field Trial
75	JC193	1397/07/07	Percutaneous Ethanol Injection for Benign Cystic and Mixed Thyroid Nodules
76	JC192	1397/07/07	Cancer Incidence in Patients With Acromegaly: A Cohort Study and Meta-Analysis of the Literature
77	JC191	1397/03/19	Lactation Duration and Progression to Diabetes in Women Across the Childbearing Years The 30-Year CARDIA Study
78	JC190	1397/03/19	Combination therapy of anabolic agents and bisphosphonates on bone mineral density in patients with osteoporosis: a meta-analysis of randomised controlled trials
79	JC189	1397/03/12	Use of Hormone Replacement in Females with Endocrine Disorders
80	JC188	1397/03/12	Estrogen Replacement in Turner Syndrome: Literature Review and Practical Considerations
81	JC187	1397/03/05	Meat Cooking Methods and Risk of Type 2 Diabetes: Results From Three Prospective Cohort Studies
82	JC186	1397/02/29	Update on Diabetic Nephropathy: Core Curriculum 2018
83	JC185	1397/02/29	Bilateral Adrenalectomy in Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis
84	JC183	1397/02/22	Effect of Glyburide vs Subcutaneous Insulin on Perinatal Complications Among Women With Gestational Diabetes A Randomized Clinical Trial
85	JC184	1397/02/22	2018European Thyroid Association (ETA) Guidelines for the Management of Amiodarone-Associated Thyroid Dysfunction
86	JC182	1397/02/15	Second Radioiodine Treatment: Limited Benefit for Differentiated Thyroid Cancer With Locoregional Persistent Disease
87	JC181	1397/02/15	High Serum Cholesterol Is a Novel Risk Factor for Graves’ Orbitopathy: Results of a Cross-Sectional Study
88	JC179	1397/02/08	Reducing Cholesterol and Fat Intake Improves Glucose Tolerance by Enhancing b Cell Function in Nondiabetic Subjects
89	JC180	1397/02/08	Maternal Thyroid Function in Early Pregnancy and Neuropsychological Performance of the Child at 5 Years of Age
90	JC178	1397/02/01	Decreasing Use of Radioactive Iodine for Low-Risk Thyroid Cancer in California, 1999 to 2015
91	JC177	1397/02/01	Effects of Levothyroxine on Pregnant Women With Subclinical Hypothyroidism, Negative for Thyroid Peroxidase Antibodies
92	JC175	1397/01/18	Lower Trabecular Bone Score in Patients With Primary Aldosteronism: Human Skeletal Deterioration by Aldosterone Excess
93	JC176	1397/01/18	Natural History of Contralateral Nodules After Lobectomy in Patients With Papillary Thyroid Carcinoma
94	JC174	1396/12/19	Low Incidence of End-Stage Renal Disease in Childhood-Onset Type 1 Diabetes Followed for Up to 42 Years
95	JC173	1396/12/19	Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes
96	JC171	1396/12/12	Comparative Safety of Sulfonylureas and the Risk of Sudden Cardiac Arrest and Ventricular Arrhythmia
97	JC172	1396/12/12	The Value of Perioperative Levels of ACTH, DHEA, and DHEA-S and Tumor Size in Predicting Recurrence of Cushing Disease
98	JC170	1396/12/05	Clinical Fractures Among Older Men With Diabetes Are Mediated by Diabetic Complications
99	JC169	1396/12/05	Recent Pregnancy Is Not Associated with High-Risk Pathological Features of Well-Differentiated Thyroid Cancer
100	JC167	1396/11/28	Males with prolactinoma are at increased risk of incident cardiovascular disease
101	JC168	1396/11/28	Serum 25- hydroxyvitamin D as a predictor of mortality and cardiovascular events: A 20- year study of a community- based cohort
102	JC166	1396/11/21	PTH(1–34) for Surgical Hypoparathyroidism: A 2-Year Prospective, Open-Label Investigation of Efficacy and Quality of Life
103	JC165	1396/11/21	Quality of Life in Primary Aldosteronism: A Comparative Effectiveness Study of Adrenalectomy and Medical Treatment
104	JC163	1396/11/14	Prolactinoma management predictors of remission and recurrence after dopamine agonists withdrawal
105	JC164	1396/11/14	Prevention of total thyroidectomy in noninvasive follicular thyroid neoplasm with papillary- like nuclear features (NIFTP) based on combined interpretation of ultrasonographic and cytopathologic results
106	JC162	1396/11/07	Survival in Response to Multimodal Therapy in Anaplastic Thyroid Cancer
107	JC161	1396/11/07	Bone Turnover Markers After Sleep Restriction and Circadian Disruption: A Mechanism for Sleep-Related Bone Loss in Humans
108	JC159	1396/10/30	Diabetes in Iran: Prospective Analysis from First Nationwide Diabetes Report of National Program for Prevention and Control of Diabetes (NPPCD-2016)
109	JC160	1396/10/30	Sex Difference in the Clinical Presentation of Primary Hyperparathyroidism: Influence of Menopausal Status
110	JC158	1396/10/23	The Role of Age and Excess Body Mass Index in Progression to Type 1 Diabetes in At-Risk Adults
111	JC157	1396/10/23	Low Plasma Adiponectin Concentrations Predict Increases in Visceral Adiposity and Insulin Resistance
112	JC155	1396/10/16	Air Pollution and Mortality in the Medicare Population
113	JC156	1396/10/16	DPP4 Inhibitor Sitagliptin as a Potential Treatment Option in Metformin Intolerant Obese Women with Polycystic Ovary Syndrome: a Pilot Randomized Study
114	JC154	1396/10/09	Health Effects of Overweight and Obesity in 195 Countries over 25 Years
115	JC153	1396/10/09	Differential Growth Rates of Benign vs. Malignant Thyroid Nodules
116	JC151	1396/10/02	Magnesium Intake, Quality of Carbohydrates, and Risk of Type 2 Diabetes: Results From Three U.S. Cohorts
117	JC152	1396/10/02	Maternal Thyroid Antibodies Associates With Cardiometabolic Risk Factors in Children at the Age of 16
118	JC150	1396/09/25	Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis
119	JC149	1396/09/25	Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial
120	JC147	1396/09/18	Associations of Fats and Carbohydrate Intake with Cardiovascular Disease and Mortality in 18 Countries from Five Continents (PURE): A Prospective Cohort Study
121	JC148	1396/09/18	Magnesium Intake, Quality of Carbohydrates, and Risk of Type 2 Diabetes: Results From Three U.S. Cohorts
122	JC146	1396/09/11	Incidence, Demographics, and Clinical Characteristics of Diabetes of the Exocrine Pancreas (Type 3c): A Retrospective Cohort Study
123	JC145	1396/09/11	Prognostic Value of Preoperative Anti- Thyroglobulin Antibody in Differentiated Thyroid Cancer
124	JC144	1396/09/04	Diabetes, Prediabetes, and BrainVolumes and Subclinical Cerebrovascular Disease on MRI: The Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS)
125	JC145	1396/09/04	The 2017 Bethesda System for Reporting Thyroid Cytopathology
126	JC143	1396/08/27	Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
127	JC142	1396/08/27	Changes in Visceral Adiposity, Subcutaneous Adiposity, and Sex Hormones in the Diabetes Prevention Program
128	JC140	1396/08/20	Parity and Risk of Thyroid Autoimmunity Based on the NHANES (2001–2002, 2007–2008, 2009–2010,and 2011–2012)
129	JC141	1396/08/20	Risk of Recurrence in Pituitary Neuroendocrine Tumors: A Prospective Study Using a Five-Tiered Classification
130	JC139	1396/08/13	The Prognostic Value of Tumor Multifocality in Clinical Outcomes of Papillary Thyroid Cancer
131	JC138	1396/08/13	The Effect of Improved Serum 25-Hydroxyvitamin D Status on Glycemic Control in Diabetic Patients
132	JC136	1396/08/06	Long-Term Antithyroid Drug Treatment
133	JC137	1396/08/06	Pituitary Tumor Suppression by Combination of Cabergoline and Chloroquine
134	JC135	1396/07/29	Thymic Hyperplasia Associated with Graves’ Disease Pathophysiology and Proposed Management Algorithm
135	JC134	1396/07/29	Hemoglobin Glycation Index Is Associated With Cardiovascular Diseases in People With Impaired Glucose Metabolism
136	JC132	1396/07/22	Obesity and Metabolic Unhealthiness Have Different Effects on Colorectal Neoplasms
137	JC133	1396/07/22	Management of Inpatient Hyperglycemia and Diabetes in Older Adults
138	JC131	1396/07/15	Distinguishing Parathyroid and Thyroid Lesions on Ultrasound-Guided Fine-Needle Aspiration: A Correlation of Clinical Data, Ancillary Studies, and Molecular Analysis
139	JC130	1396/07/15	TERT, BRAF ,and NRAS in Primary Thyroid Cancer and Metastatic Disease
140	JC128	1396/07/01	β Cells Persist in T1D Pancreata Without Evidence of Ongoing β-Cell Turnoveror Neogenesis
141	JC129	1396/07/01	Subclinical Hypothyroidism
142	JC127	1396/04/17	Role of First-Trimester HbA1c as a Predictor of Adverse Obstetric Outcomes in a Multiethnic Cohort
143	JC126	1396/04/17	Metabolically Healthy Obesity and Ischemic Heart disease
144	JC124	1396/04/10	Dynamic Risk Stratiﬁcation for Predicting Recurrence in Patients with Differentiated Thyroid Cancer Treated Without Radioactive Iodine Remnant Ablation Therapy
145	JC125	1396/04/10	In Vitro Head-to-Head Comparison Between Octreotideand Pasireotide in GH-Secreting Pituitary Adenomas
146	JC123	1396/04/03	Effect of Liraglutide Therapy on Liver Fat Content in Patients With InadequatelyPatients With Inadequately Controlled Type 2 Diabetes
147	JC122	1396/04/03	Chronic Intranasal Insulin Does Not Affect Hepatic Lipids but Lowers Circulating BCAAs in Healthy Male Subjects
148	JC120	1396/03/27	Metabolically Healthy Obesity and Ischemic Heart disease
149	JC119	1396/03/27	Effects of Cholecalciferol vs Calcifediol on Total andFree 25-Hydroxyvitamin D and Parathyroid Hormone
150	JC121	1396/03/27	Role of First-Trimester HbA1c as a Predictor of Adverse Obstetric Outcomes in a Multiethnic Cohort
151	JC118	1396/03/20	Skeletal Complications and Mortality in Thyroid Cancer
152	JC117	1396/03/20	Duodenal Mucosa of Patients With Type 1 DiabetesShows Distinctive Inflammatory Profile and Microbiota
153	JC116	1396/03/13	Effects of Metreleptin in Pediatric Patients eith lipodystrophy
154	JC115	1396/03/13	Characteristics of Pediatric vs Adult pheochromocytomas and paragangliomas
155	JC114	1396/03/06	Thyroid Hormone Therapy for Older Adults with subclinical hypothyroidism
156	JC113	1396/03/06	Clinical Features of Early and Late Postoperative hypothyroidism after lobectomy
157	JC112	1396/02/30	Bone Turnover Is Suppressed in Insulin Resistance, Independent of Adiposity
158	JC111	1396/02/16	Long-Term Effect of Adrenalectomy on Cardiovascular Remodeling in Patients With Pheochromocytoma
159	JC110	1396/02/09	Thiazide Treatment in Primary Hyperparathyroidism—A New Indication for an Old Medication
160	JC109	1396/02/09	Long-Term Quality of Life in Adult Survivors of Pediatric Differentiated Thyroid Carcinoma
161	JC108	1396/02/02	Practical Performance of the 2015 American Thyroid Association Guidelines for Predicting Tumor Recurrence in Patients with Papillary Thyroid Cancer in South Korea
162	JC107	1396/01/26	Thyroglobulin as a Functional Biomarker of Iodine Status in a Cohort Study of Pregnant Women in the United Kingdom
163	JC106	1396/01/19	Low-Dose Aspirin and Sporadic Anovulation
164	JC105	1396/01/19	Characteristics of Men Who Report Persistent Sexua lSymptoms After Finasteride Use for Hair Loss
165	JC104	1395/12/14	No Increase in Fractures After Stopping Hormone Therapy: Results From the Women’s Health Initiative
166	JC103	1395/12/14	Effects of Oxandrolone on Cardiometabolic Health in Boys With Klinefelter Syndrome: A Randomized Controlled Trial
167	JC102	1395/12/07	Vertebral Fractures and Bone Mineral Density in Patients With Idiopathic Hypoparathyroidism on Long-Term Follow-Up
168	Jc101	1395/12/07	The Desmopressin Test Predicts Better Than Basal Cortisol the Long-Term Surgical Outcome of Cushing’s Disease
169	JC100	1395/11/30	Urinary Citrate, an Index of Acid-Base Status, Predicts Bone Strength in Youths and Fracture Risk in adult females
170	JC99	1395/11/23	The Effect of TSH Suppression on Vertebral Trabecular Bone Scores in Patients With Differentiated thyroid carcinoma
171	JC98	1395/11/23	Clinical, Sonographic, and Pathological Characteristics of RAS-Positive Versus BRAF-Positive Thyroid Carcinoma
172	JC97	1395/11/16	Diffuse Sclerosing Variant of Papillary Thyroid Carcinoma Is Associated With Aggressive Histopathological Features and a Poor Outcome: Results of a Large Multicentric Study
173	JC96	1395/11/09	Drug-induced HPA axis alterations during acute critical illness: a multivariable association study
174	JC95	1395/11/09	Dietary Sodium Restriction Increases the Risk of Misinterpreting Mild Cases of Primary Aldosteronism
175	JC92		Long-Term Outcomes Following Therapy in Differentiated Thyroid Carcinoma: NTCTCS Registry Analysis 1987–2012
176	JC88		Abnormal Responsiveness to Dexamethasone-Suppressed CRH Test in Patients With Bilateral Adrenal Incidentalomas
177	JC84		Triglyceride Levels and Fracture Risk in Midlife Women: Study of Women’s Health Across the Nation (SWAN)
178	JC80		Subclinical hypothyroidism and cognitive function in people over 60 years: a systematic review and meta-analysis
179	JC76		Risk Stratification of Neck Lesions Detected Sonographically During the Follow-Up of Differentiated Thyroid Cancer
180	JC72		Plasma DPP4 Activities Are Associated With Osteoporosis in Postmenopausal Women With Normal Glucose Tolerance
181	JC68		Maternal Thyroid Disease and Preterm Birth: Systematic Review and Meta-Analysis
182	JC64		Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes: The DCCT/EDIC Study 30-Year Follow-up
183	JC60		Insulin Dose and Cardiovascular Mortality in the ACCORD Trial
184	JC56		Follow-up of Glycemic Control and Cardiovascular Outcomes in Type 2 Diabetes
185	JC52		Excess Mortality among Persons with Type 2 diabetes
186	JC48		Diabetes Incidence and Glucose Tolerance after Termination of Pioglitazone Therapy: Results from ACT NOW
187	JC44		Clomiphene Citrate for Treatment of Acromegaly Not Controlled by Conventional Therapies
188	JC40		AMH measurement vesus ovarian ultrasound in the diagnostics of polycystic ovary syndrome in different phenotypes
189	JC36		A Novel Insulin Resistance Index to Monitor Changes in Insulin Sensitivity and Glucose Tolerance: the ACT NOW Study
190	JC32		American Association of Clinical Endocrinologists and American College of Endocrinology disease state Clinical review: Postoperative Hypoparathyroidism- Definitions and Managment
191	JC28		Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR 45 mLmin)
192	JC24		Endocrine role of bone: recent and emerging perspectives beyond osteocalcin
193	JC20		Imaging of the parathyroid glands in primary hyperparathyroidism
194	JC16		Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research
195	JC12		Pituitary apoplexy
196	JC8		The Management of Primary Aldosteronism Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline
197	JC4		Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline
198	JC91		Is a second recombinant human thyrotropin stimulation test useful? The value of postsurgical undetectable stimulated thyroglobulin level at the time of remnant ablation on clinical outcome
199	JC87		Vitamin D in Primary Hyperparathyroidism: Effects on Clinical, Biochemical, and Densitometric Presentation
200	JC83		The Relationship Between Parathyroid Hormone and 25-Hydroxyvitamin D During and After Pregnancy
201	JC79		Sex-Dimorphic Effects of Prenatal Treatment With Dexamethasone
202	JC75		Pre-pregnancy adverse lipid profile and subsequent risk of gestational diabetes
203	JC71		Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
204	JC67		Long-Term Outcomes Following Therapy in Differentiated Thyroid Carcinoma: NTCTCS Registry Analysis 1987–2012
205	JC63		Intensive Diabetes Therapy and Ocular Surgery in Type 1 Diabetes
206	JC59		Increasing maternal obesity is associated with alterations in both maternal and neonatal thyroid hormone levels
207	JC55		Factors Associated With Cardiovascular Events in Patients With Type 2 Diabetes and Acute Myocardial infarction
208	JC51		Effects of RAS inhibitors on diabetic retinopathy: a systematic review and meta-analysis
209	JC47		Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates
210	JC43		Circulating Cytokines Predict the Development of Insulin Resistance in a Prospective Finnish Population Cohort
211	JC39		Ambient Light Exposure and Changes in Obesity Parameters: A Longitudinal Study of the HEIJO-KYO Cohort
212	JC35		A Novel and Practical Screening Tool for the Detection of Silent Myocardial Infarction in Patients With Type 2 Diabetes
213	JC31		American Association of Clinical Endocrinologists, American College of Endocrinology disease state Clinical review. Clinical Relevance of Macroprolactin in the Absence or Presence of true Hyperprolactinemia
214	JC27		Delaying Radioactive Iodine Ablation for up to One Year Does Not Increase Recurrence for Patients with Differentiated Thyroid Cancer
215	JC23		Euglycemic Diabetic Ketoacidosis: A Predictable, Detectable, and Preventable Safety Concern With SGLT2 Inhibitors
216	JC19		Less is More: Comparing the 2015 and 2009 American Thyroid Association Guidelines for Thyroid Nodules and Cancer
217	JC15		Medical Management of Extrathyroidal Manifestation of Graves Disease
218	JC11		Pituitary Tumor Management in Pregnancy
219	JC7		Thyroid and Pregnancy in Tehran, Iran: Objectives and Study Protocol
220	JC3		Underdiagnoses and Undertreatment of Osteoporosis: The Battle to Be Won
221	JC94		Serum ﬁbroblast growth factor 21 is a superior biomarker to other adipokines in predicting incident diabetes
222	JC90		Efficacy and Safety of an Injectable Combination Hormonal Contraceptive for Men
223	JC86		Use of Estrogen-Containing Contraception Is Associated With Increased Concentrations of 25-Hydroxy Vitamin D
224	JC82		The Association Between Sleep Duration, Insulin Sensitivity, and -Cell Function: The EGIR-RISC Study
225	JC78		Salivary Cortisone Reflects Cortisol Exposure Under Physiological Conditions and After Hydrocortisone
226	JC74		Preconception Low Dose Aspirin and Time to Pregnancy: Findings From the Effects of Aspirin in Gestation and Reproduction Randomized Trial
227	JC70		Oral carnitine supplementation reduces body weight and insulin resistance in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial
228	JC66		Long-Term Outcome in Levothyroxine Treated Patients With Subclinical Hypothyroidism and concomitant heart disease
229	JC62		Intake of Lactobacillus reuteri Improves Incretin and Insulin Secretion in Glucose-Tolerant Humans: A Proof of Concept
230	JC58		Increased Risk of Atrial Fibrillation After Treatment for Differentiated Thyroid Carcinoma
231	JC54		Experience in optimizing fertility outcomes in men with congenital adrenal hyperplasia due to 21 hydroxylase deficiency
232	JC50		Effect of atorvastatin on glycaemia progression in patients with diabetes: an analysis from the Collaborative Atorvastatin in Diabetes Trial (CARDS)
233	JC46		Defining the Newborn Blood Spot Screening Reference Interval for TSH: Impact of Ethnicity
234	JC42		Association Between Hyponatremia, Osteoporosis,and Fracture A Systematic Review and Meta-analysis
235	JC38		ACTH stimulation tests for the diagnosis of adrenal insufficiency: Systematic review and meta-analysis
236	JC34		Acid–Base Problems in Diabetic Ketoacidosis
237	JC30		Antithyroid Drug Use in Pregnancy and Birth Defects: Why Some Studies Find Clear Associations, and Some Studies Report None
238	JC26		Dyslipidemia in Pregnancy
239	JC22		Factitious Graves’ Disease Due to Biotin Immunoassay Interference—A Case and Review of the Literature
240	JC18		Limitation of Current Approaches for the Treatment of Acromegaly
241	JC14		Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations
242	JC10		Successful Treatment of Type B Insulin Resistance With Rituximab
243	JC6		Thyroid Nodules
244	JC2		American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part2
245	JC93		Randomized Trial of Aromatase Inhibitors, Growth Hormone, or Combination in Pubertal Boys with Idiopathic, Short Stature
246	JC89		Cross-Sex Hormone Treatment and Psychobiological Changes in Transsexual Persons: Two-Year Follow-Up Data
247	JC85		Use of Antibiotics and Risk of Type 2 Diabetes: A Population-Based Case-Control Study
248	JC81		The Association Between Air Pollution Exposure and Glucose and Lipids Levels
249	JC77		Risk Stratification of Thyroid Incidentalomas Found on PET/CT: The Value of Iodine Content on Noncontrast Computed Tomography
250	JC73		Preablative Stimulated Thyroglobulin Correlates to New Therapy Response System in Differentiated Thyroid Cancer
251	JC69		Mechanisms of Action of Liraglutide in Patients With Type 2 Diabetes Treated With High-Dose Insulin
252	JC65		Is insulin-like growth factor-I a good marker for treatment adherence in growth hormone deficiency in adulthood
253	JC61		Insulin Enhances Endothelial Function Throughout the Arterial Tree in Healthy But Not Metabolic syndrome subjects
254	JC57		Hypothyroidism Following Hemithyroidectomy: Incidence, Risk Factors, and Clinical Characteristics
255	JC53		Exercise Training Reduces Liver Fat and Increases Rates of VLDL Clearance But Not VLDL Production in NAFLD
256	JC49		Does Sitagliptin Affect the Rate of Osteoporotic Fractures in Type 2 Diabetes? Population-Based Cohort Study
257	JC45		Dapagliflozin as Additional Treatment to Liraglutide and Insulin in Patients With Type 1 Diabetes
258	JC41		Association Between HbA1c Variability and Risk of Microvascular Complications in Adolescents With type 1 diabetes
259	JC37		Abnormal Responsiveness to Dexamethasone-Suppressed CRH Test in Patients With Bilateral Adrenal Incidentalomas
260	JC33		American Association of Clinical Endocrinologists and American College of Endocrinology 2016 Outpatient Glucose Monitoring Consensus Statement
261	JC29		Certain Clinical Features and Treatments May Be Associated with Increased Mortality in Thyroid Storm
262	JC25		Elevated PTH with normal serum calcium level: a structured approach
263	JC21		Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline
264	JC17		Low-Risk Differentiated Thyroid Cancer and Radioiodine Remnant Ablation: A Systematic Review of the Literature
265	JC13		Outcome of adrenal sparing surgery in heritable pheochromocytoma
266	JC9		The Emerging role of Adjunctive noninsulin Antihyperglycemic therapy in the Management of type 1 Diabetes
267	JC5		Thyrotoxicosis associated with the use of amiodarone: the utility of ultrasound in patient management
268	JC1		American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part1